Finasteride to Reduce Bleeding in Transurethral Resection of the Prostate in Patients with Foley Catheter

    January 2014 in “ Revista del Hospital Juárez de México ”
    J Alberto Salazar-Vázquez, Juan Antonio Lugo-García
    Image of study
    TLDR Finasteride reduces bleeding during prostate surgery.
    The study investigated the use of finasteride, a 5 alpha-reductase inhibitor, in reducing intraoperative bleeding during transurethral resection of the prostate (TURP) in patients with a Foley catheter for over a month. Involving 80 patients divided into two groups, the experimental group received 5 mg of finasteride daily for one month before surgery. Results showed that the finasteride group experienced significantly less bleeding (180.00 ± 91.14 mL) compared to the control group (286.25 ± 100.63 mL), with reduced need for blood transfusions and shorter hospital stays, as 90% were discharged after one day. The study concluded that preoperative finasteride effectively reduced bleeding during TURP, likely by decreasing prostatic tissue neovascularization, and recommended its use for patients undergoing TURP, especially those with long-term Foley catheters, due to its cost-benefit advantage in reducing surgical morbidity.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  41 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Just popped my first fin, excited as hell!

      in Finasteride/Dutasteride  154 upvotes 1 year ago
      A user shared their excitement about starting finasteride for hair loss after trying various ineffective methods. Other users discussed their experiences with finasteride, including shedding phases and side effects, with one mentioning using topical finasteride and minoxidil.

    Similar Research

    6 / 1000+ results